Nagesh Kumar Middey

Amministratore Delegato presso Celon Laboratories Ltd.

Miscellaneous

Health Technology

Consumer Services

Profilo

Nagesh Kumar Middey is currently the Chief Executive Officer & Director at Celon Laboratories Ltd.
since 2018 and the Director at Mviyes Pharma Ventures Pvt Ltd.
since 2017.
He graduated from Osmania University.

Posizioni attive di Nagesh Kumar Middey

Società	Posizione	Inizio
Mviyes Pharma Ventures Pvt Ltd. Mviyes Pharma Ventures Pvt Ltd. MiscellaneousMiscellaneous Mviyes Pharma Ventures Pvt Ltd. operates as a holding company. The company was founded on March 30, 2017 and is headquartered in Hyderabad, India.	Direttore/Membro del Consiglio	30/03/2017
Celon Laboratories Ltd. Celon Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Celon Laboratories Ltd. develops and markets pharmaceuticals products. Its products include oncology and critical care which encompass Alakcel, Capcel, Celcarb, Celdaz, Celplat, Celtax, Celofos, and Temolon, critical care include Arium, Buloc, Hypro and Hypro Melt, Vibro, and Stimin and Stimin G. The company was founded by K. V. Ravindra in 2007 and is headquartered in Hyderabad, India.	Amministratore Delegato	01/10/2018

Tutte le posizioni attive di Nagesh Kumar Middey

Formazione di Nagesh Kumar Middey

Osmania University

Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Nagesh Kumar Middey

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Mviyes Pharma Ventures Pvt Ltd. Mviyes Pharma Ventures Pvt Ltd. MiscellaneousMiscellaneous Mviyes Pharma Ventures Pvt Ltd. operates as a holding company. The company was founded on March 30, 2017 and is headquartered in Hyderabad, India.	Miscellaneous
Celon Laboratories Ltd. Celon Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Celon Laboratories Ltd. develops and markets pharmaceuticals products. Its products include oncology and critical care which encompass Alakcel, Capcel, Celcarb, Celdaz, Celplat, Celtax, Celofos, and Temolon, critical care include Arium, Buloc, Hypro and Hypro Melt, Vibro, and Stimin and Stimin G. The company was founded by K. V. Ravindra in 2007 and is headquartered in Hyderabad, India.	Health Technology